RxDoctor Payments Data

Bennie Diamond, MD

Family Medicine · Fort Mill, SCNPI 1932769312

Payments from drug & device makers

$514in general payments, 2019–2025

Across 23 payments — averaging $22.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$140
  • Silk Road Medical, Inc.$138
  • Merck$75
  • AbbVie$39
  • Novo Nordisk$35
  • Amgen$33
  • plus $52 from 3 others

What the payments were for

  • Food & beverage$514100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$514 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$82,306
Medicare patients
280
Services billed
1,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide67$78,852
JardianceEmpagliflozin55$72,387
EliquisApixaban55$56,709
WegovySemaglutide38$55,732
TrulicityDulaglutide46$55,562
MounjaroTirzepatide28$52,012
JanuviaSitagliptin Phosphate20$25,913
FarxigaDapagliflozin Propanediol16$24,300
TradjentaLinagliptin32$23,805
XareltoRivaroxaban17$22,312
VascepaIcosapent Ethyl19$14,397
Tresiba Flextouch U-100Insulin Degludec14$14,182
MyrbetriqMirabegron14$14,022
LinzessLinaclotide24$12,549
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$11,973

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$35$134,584105 claims
PfizerEliquis$140$56,70955 claims
MerckJanuvia$75$25,91320 claims
AstraZenecaFarxiga$11$24,30016 claims
AbbVieLinzess, Synthroid$39$14,59645 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Fort Mill

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →